/People

Guy Harmelin

Investor

Chief Investment Officer, Advanced Technology at MGX

Find your path to Guy

Sign up to see every warm intro you have to Guy

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Guy. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Dr. Guy Harmelin is a physician-turned-investor and serial biotech founder (RondinX/BiomX NYSE; Ayala Pharmaceuticals Nasdaq) with Oxford Nanopore board experience and a $750K–$10M life sciences and industrials investment focus.

Invests in

AI & Machine LearningBiotechData & InfrastructureRoboticsSemiconductors

Colleagues at MGX

Frequently asked questions

Who is Guy Harmelin?
Dr. Guy Harmelin is a physician-turned-investor and serial biotech founder (RondinX/BiomX NYSE; Ayala Pharmaceuticals Nasdaq) with Oxford Nanopore board experience and a $750K–$10M life sciences and industrials investment focus.
Where does Guy Harmelin work?
Guy Harmelin is Chief Investment Officer, Advanced Technology at MGX.
What does Guy Harmelin invest in?
Guy Harmelin invests in AI & Machine Learning, Biotech, Data & Infrastructure, Robotics, Semiconductors.

About this profile. Compiled from public sources — MGX's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights